Alan Cohen

Senior Vice President & Chief Medical Officer - Clinical Development & Medical Affairs at Metagenomi in March 2022 to April 2023

Vice President - Global Medical Affairs at Eidos Therapeutics in April 2020 to March 2022

Global Clinical Leader - Pediatric & Orphan Drug Disease Development at Bayer in March 2018 to April 2020

Venture Capital/Investment Firm - Medical Advisor & Consultant at Brace Pharma Capital in February 2016 to December 2019

Adjunct, Clinical Teaching Faculty at Stanford University School of Medicine in January 2006 to March 2019

Senior Vice President - Global Clinical & Med Affairs at Aridis Pharmaceuticals, Inc. in July 2017 to March 2018

Senior Vice President & Chief Medical Officer at Therabron Therapeutics, Inc in February 2016 to May 2017

Chief Medical Officer at Eddingpharm in March 2014 to February 2016

Executive Director - Clinical Development & Medical Affairs - Respiratory at Boehringer Ingelheim in December 2012 to February 2014

Senior Vice President - Medical Affairs at InterMune in November 2009 to December 2012

Vice President- Clinical Development & Medical Affairs at MAP Pharmaceuticals in August 2008 to November 2009

Chief Medical Officer, Vice President - Clin Development, Med Affairs - Safety & Pharmacovigilance at Jazz Pharmaceuticals in January 2006 to August 2008

Senior Director, Medical Affairs at MedImmune in January 2001 to January 2005

Clinical Faculty, Dept of Pediatric Pulmonary Medicine at Johns Hopkins School of Medicine in January 2001 to January 2005

Assistant Professor, Dept of Pediatrics at Morehouse School of Medicine in January 1998 to January 2001

MD, Pediatric Pulmonologist & Director Clinical Reseach at Georgia Pediatric Pulmonology Associates in January 1998 to January 2001

Assistant Professor, Co-Director Pediatric Lung Transplant Program at Washington University School of Medicine in January 1995 to January 1998